Grisnilimab setaritox Antibody
Grisnilimab setaritox is an anti-CD7 immunotoxin incorporating ricin A chain (RTA) that exhibits potent in vitro cytotoxicity against T-cell leukemias. Its RTA component inhibits protein synthesis by disrupting ribosomes. This construct has also shown activity in an in vivo model of leukemic meningitis.
Product Specifications
Target
Immunology/Inflammation related
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog